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Abstract 
Background: Currently, the development of gerontology as a related medical and 
biological discipline follows the path of concepts; there are three of them in classical 
gerontology: frailty, intrinsic capacity and resilience, and in preventive medicine – 
one – premature aging. The aim of the study: To study the features of cognitive 
functioning of people with various clinical and biological variants of premature ag-
ing. At the same time, insufficient attention is paid to cognitive and psychological 
functionality, which is largely the basis for the formation of resilience. Materials 
and methods: The study included 1214 people. All of them were divided into two 
groups. Subgroups were identified in each group, depending on the presence of a par-
ticular clinical and biological variant of premature aging. All patients included in the 
study underwent cognitive psychological testing. Results: The most risky options of 
premature aging are cardiac, cerebral, mitochondrial, menopausal (in women), an-
dropausal (in men) and mixed variants of premature aging. Moreover, with increas-
ing age, gender differences increase. In the 55-64-year-old age group with mitochon-
drial, andropausal, and mixed variants of premature aging, the cognitive vulnerability 
of men was higher than that of women. So, if in women in the 55-64-year-old age 
group with the mitochondrial variant in women, the MMSE test score was 28.2±0.08 
points, then in men – 24.4±0.07 (p<0.05). In the menopausal variant, the MMSE test 
score was 27.1±0.04 points, in the andropausal variant in men – 24.2±0.03 (p<0.05). 
In the mixed variant, the MMSE test score for women was 25.1±0.16 points, while 
for men it was 23.2±0.16 (p<0.05). Conclusion: 55-64-year-old men and women are 
most susceptible to cognitive and psychological vulnerability in mitochondrial, men-
opausal (in women), andropausal (in men) and mixed variants of premature aging, 
and being a male further increases this vulnerability.  
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Introduction. Currently, the develop-
ment of gerontology as a related medical and 
biological discipline follows the path of con-
cepts; there are three of them in classical ger-
ontology: frailty, intrinsic capacity and resili-
ence, and in preventive gerontology there is 
one concept (premature aging) [1, 2]. Frailty 
syndrome (FS) is a manifestation of various 
diseases against the background of age-related 
changes that manifests itself in the form of 
increased vulnerability of the body to various 
factors of the internal and external environ-
ment with the rapid development of adverse 
outcomes for health and quality of life [3, 4]. 
Intrinsic capacity (IC) is the totality of all 
physical and mental abilities of a person, 
which is divided into five domains: ability to 
move, sensory abilities (vision and hearing), 
vitality (energy level and balance), cognitive 
ability and psychological characteristics. Usu-
ally the concept of the environment, in which 
a person lives, is considered together with the 
IC, it includes such positions as devices and 
technologies that improve movement, sensory 
abilities that leads to an increase in the quality 
of life; natural and artificial living environ-
ment; emotional support and help from other 
people, communication with animals; rela-
tionships with other people; the pres-
ence/absence of special services that work 
with the elderly [5, 6]. At the junction of the 
environment and IC there is an elderly per-
son’s functional ability or functionality. 
Achieving good functionality through geriat-
ric interventions and work in order to improve 
the environment is the main goal of modern 
gerontology and geriatrics [7, 8, 9]. Resilience 
is a new concept that has been studied active-
ly in recent years. There are physical and psy-
chological types of it. Resilience is an elderly 
person’s ability to cope with stress, both 
physical (for example, a sudden increase or 
decrease in the level of physical activity) and 
psychological (retirement, loss of loved ones, 
etc.). Polypragmasia or taking drugs in high 
doses is also considered a stress factor, this is 
especially important in the treatment of severe 
coronavirus infection, when it is necessary to 
prescribe high doses of glucocorticosteroids 
to interrupt excessive immune activation, 
which can lead to post-COVID syndrome 
with hypertensive reactions, if the patient’s 
resilience is low. The formation of resilience 
is based on a complex of factors, such as ge-
netic and immune ones, the state of the intes-
tinal microbiota, as well as the level of stress 
hormones, etc. Resilience manages a quartet 
of factors including resilience-diet, resilience-
gymnastics, resilience-psychology and re-
sistance-drugs, which contribute to the 
strengthening of the physiological reserve and 
optimize the response to various stressful fac-
tors [10, 11].  
In gerontoprophylaxis the concept of 
premature aging (PA), which is characterized 
by dissociation between chronological and 
biological age, which in the biological sense 
contributes to the abnormalities of various 
functional and anatomical systems of a person 
(PA by cardiac, cerebral, osteodynapenic, 
immune, metabolic and other types), is the 
most developed [12]. However, despite the 
widespread use of the term PA, this concept 
has not still been considered from the point of 
view of prevention and rehabilitation. At the 
same time, insufficient attention is paid to 
cognitive and psychological functionality, 
which is largely the basis for the formation of 
resilience [13, 14]. 
The aim of the research is to study the 
features of cognitive functioning of people 
with various clinical and biological variants 
of premature aging.  
Materials and methods. The study in-
cluded 1214 people. All of them were divided 
into two groups. The first group included 598 
people in the age from 45 to 54, 292 men and 
306 women, the average age was   49.2±1.8. 
Subgroups were identified in each group, de-
pending on the presence of a particular clini-
cal and biological variant of premature aging. 
We distinguished cardiac, cerebral, 
ostedinapenic, mitochondrial, menopausal (in 
women), andropausal (in men), immune and 
mixed variants of premature aging (Table 1).  
The following criteria were used to di-
agnose the variants of premature aging [8]. 
The cardiac variant of premature aging oc-
curred, if the patient was diagnosed with arte-
rial hypertension and/or clinical manifesta-
tions of atherosclerosis and/or chronic heart 
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bination of two of the following signs oc-
curred: high-normal blood pressure; 
dyslipidemia with an off-centre towards the 
predominance of proatherogenic cholesterol 
fractions; reduced volume of aerobic (motor) 
physical activity (less than 150 minutes per 
week); nicotine addiction; deformed or tired 
morphotype of skin aging. 
Table 1 
Characteristics of the patients included in the study 
Variant of premature 
aging 
Age 45-54 Age 55-64 
Women Men Total Women Men Total 
No premature aging 37 38 75 33 37 70 
Cardiac 35 39 74 35 40 75 
Cerebral 33 38 71 38 41 79 
Ostedinapenic 34 35 69 42 36 78 
Mitochondrial 41 47 88 46 47 93 
Menopausal  38 - 38 45  45 
Andropausal - 35 35  41 41 
Immune 39 40 79 31 32 63 
Mixed 35 34 69 39 33 72 
Total 292 306 598 309 307 616 
 
The cerebral variant of premature aging 
was determined at the level of cognitive abili-
ties of 27 points or less according to the Min-
imental Scale Examination (MMSE); or at the 
level of cognitive abilities of 28-30 points ac-
cording to MMSE with a combination of three 
of the following signs: chronic information 
exhaustion syndrome; proven sleep disorders; 
psychoemotional background reduced to the 
level of subdepression and/or depression; re-
duced volume of aerobic (motor) physical ac-
tivity (less than 150 minutes per week); dys-
morphomania (dysmorphophobia); microbiota 
disorders; deformative, fine-wrinkled or tired 
morphotype of skin aging. The criteria for the 
osteodynapenic variant of premature aging 
were: osteoporosis and/or sarcopenia and/or 
osteoarthritis of the joints of the lower limbs; 
or a combination of two of the following signs: 
osteopenia (proven by densitometry); 
dinapenia (proven by hand dynamometry); re-
duced volume of aerobic (motor) physical ac-
tivity (less than 150 minutes per week); re-
duced frequency and volume of anaerobic 
(strength-building) physical activity (less than 
2 times a week for less than 30 minutes each 
workout); tired or fine wrinkled morphotype of 
skin aging. The mitochondrial variant of prem-
ature aging was determined when the patient 
was obese or overweight with one of the fol-
lowing signs, and with normal or reduced body 
weight – with two of the following signs: high 
normal blood pressure or arterial hypertension; 
dyslipidemia or clinical manifestations of ath-
erosclerosis; non-alcoholic steatohepatitis; the 
content of glycated hemoglobin in the blood 
serum is higher than 6.0%; deformational or 
tired morphotype of skin aging. The immune 
variant of premature aging was determined 
when the patient was assigned to the group of 
frequently and long-term patients with acute 
respiratory viral infections (if there was ARVI 
more than four times a year for more than one 
week, while COVID-19 was not taken into ac-
count) in combination with one of the follow-
ing signs: the volume of aerobic physical activ-
ity less than 150 minutes per week; reduced or 
excessive body weight; absolute zinc deficien-
cy (confirmed by laboratory tests of blood se-
rum); reduced vitamin D levels in blood se-
rum; chronic infections of the skin and its ap-
pendages; a long rehabilitation period after so-
called aggressive cosmetic proce-
dures/manipulations. The menopausal variant 
of premature aging was a cardiac, cerebral, os-
teodynapenic or mitochondrial variant of 
premature aging in women in combination 
with menopause with pathological clinical 
manifestations. The andropausal variant of 
premature aging was a cardiac, cerebral, osteo-
dynapenic or mitochondrial variant of prema-
ture aging in men in combination with age-
related androgen deficiency confirmed by la-
boratory tests. When conducting a compara-
tive analysis, the menopausal variant of wom-
en’s premature aging and the andropausal var-
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All patients included in the study un-
derwent cognitive psychological testing. The 
level of cognitive abilities was determined 
with the use of the Mini-Mental State Exami-
nation (MMSE). To assess the emotional 
sphere, the Beck Depression Inventory was 
used. Sleep quality was determined by a 10-
point reverse Visual Analoguе Scale (VAS) 
of sleep quality. 
All the results were mathematically and 
statistically processed.  
Results. The analysis of cognitive abili-
ties showed that women in the 45-54 age 
group had a statistically significant (p<0.05) 
decrease in cognitive functionality in case of 
the cerebral variant of premature aging to 
26.0±0.03 points on the MMSE scale and in 
case of the mixed variant of premature aging 
to 25.0±0.14 points compared to the level of 
29.2±0.03 points in the subgroup of women of 
the corresponding age without any signs of 
premature aging. Women in the 45-54 age 
group had a statistically significant (p<0.05) 
decrease in cognitive functionality in case of 
the cerebral variant of premature aging – up to 
25.9±0.04 points on the MMSE scale, in case 
of the menopausal variant of premature  
aging – up to 27.1±0.04 points, in case of the 
mixed variant of premature aging – up to 
25.1±0.16 points, compared with the level of 
29.0±0.04 points in the subgroup of women of 
the corresponding age without signs of 
premature aging; while in the 55-64 age group 
with the menopausal variant, the index of 
cognitive functioning was significantly lower 
(p<0.05) than in the similar variant of prema-
ture aging at the age of 45-54.     
Moreover, women in the 45-54  age 
group had a statistically significant (p<0.05) 
deterioration in the indicators of psychologi-
cal functioning, namely, there was an increase 
in the levels of depression according to the 
Beck scale in case of the cardiac variant of 
premature aging up to 15.4±1.8 points, in case 
of the cerebral variant of premature aging – 
up to 15.2±1.9 points, in case of the osteody-
napenic variant of premature aging – up to 
14.8±2.3 points, in case of the mitochondrial 
variant  of premature aging – up to 20.4±1.6 
points, in case of the menopausal variant of 
premature aging – up to 20.1±1.1 points, in 
case of the immune variant of premature ag-
ing – up to 14.6±1.5  points, in case of the 
mixed variant of premature aging – up to 
15.2±1.4 points, compared with the level of 
3.3±0.2 points in the subgroup of women of 
the corresponding age without signs of 
premature aging. At the same time, the level 
of depression in case of the mitochondrial and 
menopausal variants of premature aging was 
significantly higher (p<0.05) than in case of 
other variants of premature aging.     
Women in the 55-64 age group also had 
a statistically significant (p<0.05) deterioration 
in the indicators of psychological functioning, 
namely, there was an increase in the levels of 
depression according to the Beck scale in case 
of the cardiac variant of premature aging – up to 
15.2±1.4 points, in case of the cerebral variant 
of premature aging – up to 14.9±2.2  points, in 
case of the osteodynapenic variant of premature 
aging – up to 14.9±1.8 points, in the mitochon-
drial variant of premature aging – up to 
16.4±1.2 points, in case of the menopausal vari-
ant of premature aging – up to 15.0±1.4 points, 
in case of the immune variant of premature ag-
ing – up to 15.7±0.6 points, in case of the mixed 
variant of premature aging – up to 20.2±1.7 
points, compared with the level of 3.5±0.5 
points in the subgroup of women of the corre-
sponding age without any signs of premature 
aging. At the same time, the level of depression 
in case of the mixed variants of premature aging 
was significantly higher (p<0.05) than in other 
variants of premature aging in this age group. It 
was interesting that in contrast to the 45-54 age 
group, in the 55-64 age group there was no crit-
ical decrease in the indicators of psychological 
functioning in case of the metabolic and mito-
chondrial variants of premature aging compared 
to other variants of premature aging.  
When assessing the quality of sleep using 
a 10-point inverse VAS of sleep quality, it was 
found out that in the 45-54 age group women 
with most variants of premature aging had a 
statistically significant (p<0.05) deterioration of 
the indicators: in case of the cardiac variant of 
premature aging – up to 6.3±0.7 points, in case 
of the cerebral variant of premature aging – up 
to 6.0±0.6 points, in case of the mitochondrial 
variant of premature aging – up to 6.2±1.2 
points, in case of the menopausal variant of 
premature aging – up to 6.7±1.1 points, in case 
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6.9±1.2 points compared to the level of 1.1±0.2 
points in the subgroup of women of the corre-
sponding age without any signs of premature 
aging. At the same time, no such changes were 
detected in case of the osteodynapenic and im-
mune variants of premature aging.   
In the 55-64 age group, women with all 
(except immune) variants of premature aging 
had a statistically significant (p<0.05) deterio-
ration in sleep quality indicators: in case of 
the cardiac variant of premature aging – up to 
6.8±2.1 points, in case of the cerebral variant 
of premature aging – up to 6.5±2.4 points, in 
case of the osteodynapenic variant of prema-
ture aging – up to 5.7±2.2 points, in case  
of the mitochondrial variant of premature  
aging – up to 6.4±2.0 points, in case of the 
menopausal variant of premature aging – up 
to 8.9±0.3 points, in case of the mixed variant 
of premature aging – up to 6.0±1.2 points 
compared to the level of 1.4±0.3 points in the 
subgroup of women of the corresponding age 
without any signs of premature aging. At the 
same time, in the 55-64 age group with the 
menopausal variant, sleep quality indicators 
were significantly worse (p<0.05) than in case 
of the similar variant of premature aging at 
the age of 45-54 (Table 2). 
Changes in the indicators of cognitive 
and psychological functioning, as well as the 
quality of sleep in men, followed the same 
patterns as in women (Table 3). 
Table 2 
Functioning of the cognitive-psychological sphere indicators in women with various variants 
of premature aging 
Variant of premature 
aging 
Women, 45-54 years of age Women, 55-64 years of age 








































































































p<0.05 compared to the subgroup with no premature aging, 
**
p<0.05 compared to the subgroups with cardiac, 
cerebral, osteodynapenic, menopausal and immune variants of premature aging, 
#*
p<0.05 compared to people aged  
45-54, 
о
p<0.05 compared to other variants of premature aging. 
Table 3 
Functioning of the cognitive-psychological sphere indicators in men with various variants  
of premature aging 
Variant of premature 
aging 
Men, 45-54 years of age Men, 55-64 years of age 










































































































p<0.05 compared to the subgroup with no premature aging, 
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p<0.05 compared to subgroups with cardiac, cere-
bral, osteodynapenic, andropausal, and immune variants of premature aging, 
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p<0.05 compared to people aged 45-54, 
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Discussion. In terms of the risks of 
cognitive and psychological vulnerability mi-
tochondrial, cerebral, menopausal (in women) 
and andropausal (in men) variants of prema-
ture aging should be considered as the most 
unfavorable ones [14, 15]. However, at the 
age of 45-54 gender does not have a signifi-
cant role in increasing risks, though, when age 
increases, gender differences also increase. It 
should be noted that in the 55-64 age group 
with mitochondrial, andropausal and mixed 
variants of premature aging, the cognitive 
vulnerability of men was higher than that of 
women. Thus, in the 55-64 age group of 
women with the mitochondrial variant the 
MMSE test score was 28.2±0.08 points, while 
in men’s group – 24.4±0.07 (p<0.05). In case 
of the menopausal variant the MMSE test 
score was 27.1±0.04 points, in case of men’s 
andropausal variant – 24.2±0.03 (p<0.05). In 
case of the mixed variant the MMSE test 
score was 25.1±0.16 points for women, while 
it was 23.2±0.16 (p<0.05) for men [16, 17].   
Such patterns are potentially associated 
with two factors. The first group of factors is 
associated with the formation of a metabolic 
cardiovascular continuum that combines the 
processes of mitochondrial dysfunction, blood 
pressure dysregulation and endothelial dys-
function with their targeting in regard to brain 
tissue. The second group of reasons is associ-
ated with the peculiarities of hormonal me-
tabolism and a more significant effect on the 
cognitive sphere of age-related androgen defi-
ciency in comparison with menopausal 
changes in women [18, 19, 20]. 
Thus, premature aging in both women 
and men is a risk factor for reduced cognitive 
and psychological functionality. The riskiest 
options are cardiac, cerebral, mitochondrial, 
menopausal (in women), andropausal (in 
men) and mixed variants of premature aging. 
Conclusion. 55-64-year-old men and 
women are most susceptible to cognitive and 
psychological vulnerability in case of mito-
chondrial, menopausal (in women), andropau-
sal (in men) and mixed variants of premature 
aging. Besides, being a male increases this 
vulnerability. Patients with mitochondrial, 
menopausal (in women), andropausal (in 
men) variants of premature aging should be 
considered as a group of additional targeted 
effects when planning preventive and reha-
bilitative measures. 
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